Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized …
Objective To report the final results and cost-effectiveness analysis of a prospective
randomized controlled trial investigating drug-eluting balloon (DEB) versus plain balloon …
randomized controlled trial investigating drug-eluting balloon (DEB) versus plain balloon …
Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis
E Stabile, V Virga, L Salemme, A Cioppa… - Journal of the American …, 2012 - jacc.org
Objectives: The purpose of this prospective registry was to evaluate the safety and efficacy,
at 1 year, of the use of drug-eluting balloons (DEB) for the treatment of superficial femoral …
at 1 year, of the use of drug-eluting balloons (DEB) for the treatment of superficial femoral …
Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal …
D Scheinert, M Werner, S Scheinert, A Paetzold… - JACC: Cardiovascular …, 2013 - jacc.org
Objectives: We examined the efficacy and durability of a new interwoven self-expanding
nitinol stent system in the treatment of complex popliteal artery lesions in unselected …
nitinol stent system in the treatment of complex popliteal artery lesions in unselected …
Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing
Background The efficacy of paclitaxel-coated balloons (PCB) for restenosis prevention has
been demonstrated in humans. However, the mechanism of action for sustained drug …
been demonstrated in humans. However, the mechanism of action for sustained drug …
Drug-coated balloon vs standard percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal …
O Iida, Y Soga, K Urasawa, S Saito… - Journal of …, 2018 - journals.sagepub.com
Purpose: To assess the safety and effectiveness of the MDT-2113 (IN. PACT Admiral) drug-
coated balloon (DCB) for the treatment of de novo and native artery restenotic lesions in the …
coated balloon (DCB) for the treatment of de novo and native artery restenotic lesions in the …
Drug-eluting balloon: the comeback kid?
R Waksman, R Pakala - Circulation: Cardiovascular Interventions, 2009 - Am Heart Assoc
Balloon angioplasty revolutionized coronary revascular-ization; however, elastic recoil and
restenosis caused by cellular proliferation are major drawbacks of angioplasty. Intracoronary …
restenosis caused by cellular proliferation are major drawbacks of angioplasty. Intracoronary …
Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel?
U Speck, B Cremers, B Kelsch… - Circulation …, 2012 - Am Heart Assoc
Background—The purpose of this study was to investigate the elimination of paclitaxel from
the arterial wall after a single short administration with a coated balloon. Methods and …
the arterial wall after a single short administration with a coated balloon. Methods and …
Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs
A Kayssi, T Al‐Atassi, G Oreopoulos… - Cochrane Database …, 2016 - cochranelibrary.com
Background Atherosclerotic peripheral arterial disease (PAD) can lead to disabling ischemia
and limb loss. Treatment modalities have included risk factor optimization through life‐style …
and limb loss. Treatment modalities have included risk factor optimization through life‐style …
Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial
F Fanelli, A Cannavale, E Boatta… - Journal of …, 2012 - journals.sagepub.com
Purpose To report 6-month results of the DEBELLUM (D rug-E luting B alloon E valuation for
L ower L imb MU ltilevel Treat M ent) randomized trial to evaluate the efficacy of a drug …
L ower L imb MU ltilevel Treat M ent) randomized trial to evaluate the efficacy of a drug …
[HTML][HTML] The diagnosis and treatment of peripheral arterial vascular disease
H Lawall, P Huppert, C Espinola-Klein… - Deutsches Ärzteblatt …, 2016 - ncbi.nlm.nih.gov
Background In peripheral arterial occlusive disease (PAOD), arterial stenosis or occlusion
impairs perfusion in the territory of the distal portion of the aorta and the iliac and leg …
impairs perfusion in the territory of the distal portion of the aorta and the iliac and leg …